President of MaxCyte Maher Masoud Buys More Stock [Yahoo! Finance]
MaxCyte, Inc. (MXCT)
Company Research
Source: Yahoo! Finance
Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign. See our latest analysis for MaxCyte MaxCyte Insider Transactions Over The Last Year In fact, the recent purchase by Maher Masoud was the biggest purchase of MaxCyte shares made by an insider individual in the last twelve months, according to our records. That means that even when the share price was higher than UK£3.80 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. In our view, the price an insider pays for shares is very important. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Maher Masoud was the only individual insider to buy during the last year. You can see a visual
Show less
Read more
Impact Snapshot
Event Time:
MXCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MXCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MXCT alerts
High impacting MaxCyte, Inc. news events
Weekly update
A roundup of the hottest topics
MXCT
News
- Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services [Yahoo! Finance]Yahoo! Finance
- Does MaxCyte (MXCT) Have the Potential to Rally 85% as Wall Street Analysts Expect? [Yahoo! Finance]Yahoo! Finance
- Recent Price Trend in MaxCyte (MXCT) is Your Friend, Here's Why [Yahoo! Finance]Yahoo! Finance
- MaxCyte to Participate in William Blair 44th Annual Growth Stock ConferenceGlobeNewswire
- RGA Investment Advisors Q1 2024 Investment Commentary [Seeking Alpha]Seeking Alpha
MXCT
Earnings
- 5/7/24 - Beat
MXCT
Sec Filings
- 6/24/24 - Form 4
- 6/20/24 - Form 144
- 6/13/24 - Form 4
- MXCT's page on the SEC website